We create intelligence-driven healthcare solutions designed by practitioners for practitioners.
Dr. James Wilson is a board-certified, practicing pediatrician who specializes in operational health security intelligence, with a focus on the anticipation, detection, and warning of infectious disease crises. He has led the creation of several systems used for the anticipation and detection of infectious disease crises and disasters.
Dr. Wilson was the first operations chief of the Department of Homeland Security’s National Biosurveillance Integration Center. He led the private intelligence teams that provided tracking of H5N1 avian influenza as it spread from Asia to Europe and Africa, detection of vaccine drifted H3N2 influenza in 2007, warning of the 2009 H1N1 influenza pandemic, discovery of the United Nations as the source of the 2010 cholera disaster in Haiti, and warning of the current COVID-19 pandemic with ongoing emergency response support.
Dr. Wilson has also several investigations and live warning of alleged and confirmed laboratory accidents and biological weapon deployments. He was Guest Editor of the recent Special Issue on Health Security Intelligence in Intelligence and National Security Journal and was Co-Founder of the Global Health Security Alliance. M2 Medical Intelligence, Inc. has 25 years of health security warning intelligence experience.
David earned his master's degree in Economics from UNR (2014) and has been working in start-up business development since 2012 (DxDiscovery 2012, Strykagen co-founder 2013). These companies stem out of technologies developed by UNR medical school professors which Maine assisted in developing successful business models from concept to practice. Maine has overseen the financing, business development, and early stage research and development of a vast array of diagnostic and therapeutic opportunities for DxDiscovery and Strykagen respectively earning $6.1M and $1.1M to date.
Maine has an intimate familiarity with early stage business development, developing and implementing SBIR/STTR awards, government contracting and accounting systems, and establishing relations and securing investments with pharmaceutical partners. Recently (2017), Maine has taken his passion for startup development and experience and applied it as an instructor of entrepreneurship at TMCC community college.
Saul is machine learning and UX technologist. He received his B.S. and M.S. and Ph.D. degrees from the University of Nevada, Reno. in the Department of Computer Science and Engineering at UNR with an emphasis on Machine Learning and Software Engineering.
Utilizing the latest advances as well as a culmination of technologies, Saul architected the web services and proprietary tools used in the consumption of M2 Medical Intelligence's exposed interfaces and systems. As such, these robust systems are able to digest structured data, ensuring accurate and detailed analyses.
We are actively seeking partnership and alliances with health systems. To learn more or inquire, please fill out the form below and we’ll get back to you.
We empower complex data management to produce simple analytic outputs that dramatically improve hospital operations and patient outcomes.
Our team includes world-leading experts and visonaries in health security intelligence and emergency management.
We are actively seeking partnerships and alliances with health systems and health management companies.
Our processes manage complex data to produce easy to understand outputs, resulting in cost-effective improvements in hospital emergency preparedness and response. We marry world-leading health security intelligence with emergency management to produce a world class solution for today's difficult-to-predict emergencies.
On December 30, 2019, the M2 health security intelligence team detected report of unusual respiratory disease reported in Wuhan, China. The following day, M2 issued public notice of the Wuhan situation representing the lead crisis we were monitoring globally, and the crisis was heavily linked to San Francisco by direct, non-stop air traffic.
On Jan 1st, M2 notified the World Health Organization we were monitoring, and the communication signal pattern did not match SARS 2002-2003- an assessment validated nearly a week later with the discovery of a novel coronavirus.
On January 5th, M2 issues the first of multiple health security risk reports to its clients, emphasizing awareness as the first step to preparedness, with emphasis to check a travel history to protect the integrity of the core critical care elements of hospitals. On February 4th, M2 escalated its warning to clients. On March 22nd, this warning was escalated further based on medical infrastructure collapse reported by Lombardia, Italy. Four days later, M2, based on health security intelligence gathered from multiple countries experiencing first contact with COVID, designed and implemented a comprehensive hospital surveillance system in 10 days that is the first of its kind in the United States. This system is currently used to support the state of Nevada’s emergency response to COVID.
In August, researchers reported a significant mutation in the virus that may have contributed to enhanced transmission- this mutation first appeared in Italy in late February, with dramatic impact on Lombardia’s medical infrastructure reported during this period. M2 was unaware of the mutation, however leveraged its expert analysis to recognize a substantive change in the threat pattern of the virus and escalated warning to M2’s clients accordingly.
Partnering with us means reduced cost of care, improved patient safety and care outcomes, and proactive preparedness and response for your facility.